Cost-effectiveness of newer antiplatelet drugs

被引：0
|
作者：
Peterson, GM
Jackson, SL
机构：
来源：
ARCHIVES OF INTERNAL MEDICINE | 2003年 / 163卷 / 20期
关键词：
D O I：
10.1001/archinte.163.20.2533-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2533 / 2534
页数：2
相关论文
共 50 条
  • [21] Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes
    Franchi, Matteo
    Pellegrini, Giacomo
    Avogaro, Angelo
    Buzzetti, Giuliano
    Candido, Riccardo
    Cavaliere, Arturo
    Consoli, Agostino
    Marzona, Irene
    Mennini, Francesco Saverio
    Palcic, Stefano
    Corrao, Giovanni
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2024, 12 (03)
  • [22] Cost-effectiveness of oral antiplatelet agents—current and future perspectives
    Suzanne V. Arnold
    David J. Cohen
    Elizabeth A. Magnuson
    [J]. Nature Reviews Cardiology, 2011, 8 : 580 - 591
  • [23] Cost-Effectiveness of Genotype-Guided and Dual Antiplatelet Therapies
    Marciniak, Thomas A.
    [J]. ANNALS OF INTERNAL MEDICINE, 2014, 161 (05) : 378 - 378
  • [24] Cost-Effectiveness of Newer Antiretroviral Drugs in Treatment-Experienced Patients With Multidrug-Resistant HIV Disease
    Bayoumi, Ahmed M.
    Barnett, Paul G.
    Joyce, Vilija R.
    Griffin, Susan C.
    Sun, Huiying
    Bansback, Nick J.
    Holodniy, Mark
    Sanders, Gillian
    Brown, Sheldon T.
    Kyriakides, Tassos C.
    Angus, Brian
    Cameron, D. William
    Anis, Aslam H.
    Sculpher, Mark
    Owens, Douglas K.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 64 (04) : 382 - 391
  • [25] Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
    Zhu, Jiejin
    Zhou, Ying
    Li, Qingyu
    Wang, Gang
    [J]. ADVANCES IN THERAPY, 2023, 40 (10) : 4216 - 4235
  • [26] Cost-Effectiveness of Newer Antidiabetic Drugs as Second-Line Treatment for Type 2 Diabetes: A Systematic Review
    Jiejin Zhu
    Ying Zhou
    Qingyu Li
    Gang Wang
    [J]. Advances in Therapy, 2023, 40 : 4216 - 4235
  • [27] COST-EFFECTIVENESS OF ANTIHYPERTENSIVE DRUGS - FACT OR FANCY
    KAPLAN, NM
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1991, 4 (05) : 478 - 480
  • [28] HOW TO EVALUATE DRUGS - COST-EFFECTIVENESS ANALYSIS
    BECK, JR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 264 (01): : 83 - 84
  • [29] Cost-effectiveness of antiepileptic drugs in migraine prophylaxis
    Adelman, JU
    Adelman, LC
    Von Seggern, R
    [J]. HEADACHE, 2002, 42 (10): : 978 - 983
  • [30] Cost-effectiveness of oral antiplatelet agents-current and future perspectives
    Arnold, Suzanne V.
    Cohen, David J.
    Magnuson, Elizabeth A.
    [J]. NATURE REVIEWS CARDIOLOGY, 2011, 8 (10) : 580 - 591
12345